Abstract

Objective: To evaluate the role of DWI and ADC in differentiating benign from malignant hepaticmasses Materials and methods: Forty-one patients with fifty-two focal hepatic masses were included in our study. MRI was done using coronal T2-weighted single-shot turbo spin-echo, breath hold axial 3-D gradient-echo, breath hold 2- D gradient-echo in and out-of-phase, respiratory-triggered axial turbo spin-echo T2 sequence with fat saturation, followed by free breathing Diffusion-weighted MR imaging using a single-shot spin-echo echo planar imaging sequence and finally triphasic -MRI. Results: Forty-one patients (Fifty-two lesions) were included in our study. Twenty-three lesions were benign; eight of them were cysts (mean ADC values of 3.15 ± 0.34 × 10-3 mm2/s) and fifteen lesions were hemangiomas (mean ADC values of 2.10 ± 0.25 × 10-3 mm2/s). Twenty-nine lesions were malignant; twelve HCC lesions (mean ADC values of 1.10 ± 0.32 × 10-3 mm2/s) and seventeen masses were metastasis (mean ADC values of 0.96 ± 0.23 × 10-3 mm2/s). Sensitivity and specificity of DWI in differentiating malignant from benign hepatic masses were 96.6% and 95.7% respectively. Conclusion: DWI is an easy technique to obtain and to be evaluated. ADC values can differentiate benign from malignant liver masses with high sensitivity and specificity.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call